EC approves Pfizer's Herceptin biosimilar
admin 31st July 2018 Uncategorised 0Copycat of blockbuster breast cancer drug is Pfizer’s first oncology biosimilar
More: EC approves Pfizer's Herceptin biosimilar
Source: News
Copycat of blockbuster breast cancer drug is Pfizer’s first oncology biosimilar
More: EC approves Pfizer's Herceptin biosimilar
Source: News
© 1994 - 2026 B.M. Pharmaceuticals